相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
A. M. Roncero et al.
LEUKEMIA (2016)
Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5
Meifang Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
Diego Carrella et al.
ONCOTARGET (2016)
Inhibiting cytoplasmic accumulation of HuR synergizes genotoxic agents in urothelial carcinoma of the bladder
Jiawei Guo et al.
ONCOTARGET (2016)
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells
A. Grimaldi et al.
CANCER BIOLOGY & THERAPY (2015)
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells
Chitra Venugopal et al.
CLINICAL CANCER RESEARCH (2015)
First-line Treatment of Metastatic Disease Cisplatin-ineligible Patients
Richard Cathomas et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications
Monica Lamberti et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
Meili Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
Wei Xiang et al.
ONCOTARGET (2015)
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
Rebecca Lamb et al.
ONCOTARGET (2015)
Molecular Pathogenesis of Peripheral T Cell Lymphoma
Mamiko Sakata-Yanagimoto et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium
Minyoung Lim et al.
ACS CHEMICAL BIOLOGY (2014)
Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
Bin Li et al.
CANCER RESEARCH (2014)
The role of DNA repair pathways in cisplatin resistant lung cancer
Shane O'Grady et al.
CANCER TREATMENT REVIEWS (2014)
The impact of pyrvinium pamoate on colon cancer cell viability
Armin Wiegering et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
Bin Li et al.
PLOS ONE (2014)
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
Rebecca Lamb et al.
ONCOTARGET (2014)
Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising
Christian Jekimovs et al.
FRONTIERS IN ONCOLOGY (2014)
Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities
Mary E. Irwin et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni D. Lagadinou et al.
CELL STEM CELL (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma-Neoadjuvant and Adjuvant Settings
Cora N. Sternberg et al.
EUROPEAN UROLOGY (2013)
The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence
Ichiyo Shibahara et al.
NEURO-ONCOLOGY (2013)
Histone Acetylation-Mediated Regulation of the Hippo Pathway
Dipanjan Basu et al.
PLOS ONE (2013)
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
Wei Xu et al.
PLOS ONE (2013)
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence
Anna Grimaldi et al.
PLOS ONE (2013)
Pyrvinium targets autophagy addiction to promote cancer cell death
Longfei Deng et al.
CELL DEATH & DISEASE (2013)
Role of Systemic Chemotherapy in Urothelial Urinary Bladder Cancer
Shilpa Gupta et al.
CANCER CONTROL (2013)
Mitochondria in Cancer Stem Cells: A Target for Therapy
Rute Loureiro et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2013)
Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3
Yasuo Harada et al.
CANCER LETTERS (2012)
Role of TAZ as Mediator of Wnt Signaling
Luca Azzolin et al.
CELL (2012)
NEW SYNTHESIS OF PYRVINIUM THAT INHIBITS THE β-CATENIN/TCF4 PATHWAY
Yongjun Mao et al.
HETEROCYCLES (2012)
An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system-a unique mitochondrial energy metabolism in tumour microenvironments
Eriko Tomitsuka et al.
JOURNAL OF BIOCHEMISTRY (2012)
The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition
Wei Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells
Wesley M. Konsavage et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The Hippo Pathway
Kieran F. Harvey et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Mouse Skeletal Muscle Fiber-Type-Specific Macroautophagy and Muscle Wasting Are Regulated by a Fyn/STAT3/Vps34 Signaling Pathway
Eijiro Yamada et al.
CELL REPORTS (2012)
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Peter Bouwman et al.
NATURE REVIEWS CANCER (2012)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Skrtic et al.
CANCER CELL (2011)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma
Tiziana de Cristofaro et al.
EUROPEAN JOURNAL OF CANCER (2011)
Inducing Indigestion: Companies Embrace Autophagy Inhibitors
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
TAZ is a novel oncogene in non-small cell lung cancer
Z. Zhou et al.
ONCOGENE (2011)
Suppression of Casein Kinase 1α in Melanoma Cells Induces a Switch in β-Catenin Signaling to Promote Metastasis
Tobias Sinnberg et al.
CANCER RESEARCH (2010)
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
Yang Wang et al.
CANCER SCIENCE (2010)
Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture
Yi Arial Zeng et al.
CELL STEM CELL (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Novel strategies for treating relapsed/refractory urothelial carcinoma
Gopa Iyer et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling
Sarika Saraswati et al.
PLOS ONE (2010)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
Julia Bollrath et al.
EMBO REPORTS (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation
Oliver Renner et al.
CANCER RESEARCH (2008)
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
Violeta Serra et al.
CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
De-Hua Yu et al.
PLOS ONE (2008)
The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network
Kieran Harvey et al.
NATURE REVIEWS CANCER (2007)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
Monika Kasprzycka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome
L Nakopoulou et al.
MODERN PATHOLOGY (2006)
Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells
S Tsutsumi et al.
ONCOGENE (2006)
Wnt proteins in mammary development and cancer
KR Brennan et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Effect on tumor cells of blocking survival response to glucose deprivation
HR Park et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
MA Arap et al.
CANCER CELL (2004)
The role of autophagy during the early neonatal starvation period
A Kuma et al.
NATURE (2004)
Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H- pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
H Esumi et al.
CANCER SCIENCE (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
IK Mellinghoff et al.
CANCER CELL (2004)
A trip to the ER: coping with stress
DT Rutkowski et al.
TRENDS IN CELL BIOLOGY (2004)
Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis
M Shuda et al.
JOURNAL OF HEPATOLOGY (2003)
Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells
L Lum et al.
SCIENCE (2003)
Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production
NY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
Wnt signaling controls the phosphorylation status of β-catenin
M van Noort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Pin 1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC
A Ryo et al.
NATURE CELL BIOLOGY (2001)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions
PM Fernandez et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
